Neulasta (Pegfilgrastim): A once-per-cycle option for the management of chemotherapy-induced neutropenia

被引：34

作者：

Biganzoli, L ^{[1
]}

Untch, M

Skacel, T

Pico, JL

机构：

[1] Prato Hosp, Dept Oncol, Sandro Pitigliani Med Oncol Unit, Prato, Italy

[2] Univ Munich, Munich, Germany

[3] Amgen GmbH Europe, Luzern, Switzerland

[4] Amgen AG Europe, Neuilly Sur Seine, France

来源：

SEMINARS IN ONCOLOGY | 2004年 / 31卷 / 03期

关键词：

D O I：

10.1053/j.seminoncol.2004.04.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：27 / 34

页数：8

共 42 条

[1]

Allen RC, 1999, BLOOD, V94, p172B

[2]

[Anonymous], COMM TOX CRIT

[3] Patients aged ≤ 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy [J].

Balducci, L ;

Lyman, GH .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) :1583-1584

[4]

Balducci L, 2000, ONCOLOGY-NY, V14, P221

[5] QUANTITATIVE RELATIONSHIPS BETWEEN CIRCULATING LEUKOCYTES AND INFECTION IN PATIENTS WITH ACUTE LEUKEMIA [J].

BODEY, GP ;

BUCKLEY, M ;

SATHE, YS ;

FREIREICH, EJ .

ANNALS OF INTERNAL MEDICINE, 1966, 64 (02) :328-+

[6] CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL IN NODE-POSITIVE BREAST-CANCER - THE RESULTS OF 20 YEARS OF FOLLOW-UP [J].

BONADONNA, G ;

VALAGUSSA, P ;

MOLITERNI, A ;

ZAMBETTI, M ;

BRAMBILLA, C .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14) :901-906

[7] Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer [J].

Budman, DR ;

Berry, DA ;

Cirrincione, CT ;

Henderson, IC ;

Wood, WC ;

Weiss, RB ;

Ferree, CR ;

Muss, HB ;

Green, MR ;

Norton, L ;

Frei, E .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (16) :1205-1211

[8] The impact of Filgrastim schedule variation on hematopoietic recovery post-chemotherapy [J].

Crawford, J ;

Kreisman, H ;

Garewal, H ;

Jones, SE ;

Shoemaker, D ;

Pupa, MR ;

Armstrong, S ;

Tomita, D ;

Dziem, G .

ANNALS OF ONCOLOGY, 1997, 8 (11) :1117-1124

[9] REDUCTION BY GRANULOCYTE COLONY-STIMULATING FACTOR OF FEVER AND NEUTROPENIA INDUCED BY CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL LUNG-CANCER [J].

CRAWFORD, J ;

OZER, H ;

STOLLER, R ;

JOHNSON, D ;

LYMAN, G ;

TABBARA, I ;

KRIS, M ;

GROUS, J ;

PICOZZI, V ;

RAUSCH, G ;

SMITH, R ;

GRADISHAR, W ;

YAHANDA, A ;

VINCENT, M ;

STEWART, M ;

GLASPY, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (03) :164-170

[10] Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer:: The International Breast Cancer Study Group Trial VII [J].

Crivellari, D ;

Bonetti, M ;

Castiglione-Gertsch, M ;

Gelber, RD ;

Rudenstam, CM ;

Thürlimann, B ;

Price, KN ;

Coates, AS ;

Hürny, C ;

Bernhard, J ;

Lindtner, J ;

Collins, J ;

Senn, HJ ;

Cavalli, F ;

Forbes, J ;

Gudgeon, A ;

Simoncini, E ;

Cortes-Funes, H ;

Veronesi, A ;

Fey, M ;

Goldhirsch, A .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (07) :1412-1422

← 1 2 3 4 5 →